Sinocelltech Group Future Growth
Future criteria checks 5/6
Sinocelltech Group is forecast to grow earnings and revenue by 119.6% and 26.7% per annum respectively while EPS is expected to grow by 120.1% per annum.
Key information
119.6%
Earnings growth rate
120.1%
EPS growth rate
Biotechs earnings growth | 34.3% |
Revenue growth rate | 26.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 08 May 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 3,477 | 533 | -632 | 662 | 1 |
12/31/2024 | 2,721 | 283 | -895 | 259 | 1 |
3/31/2024 | 2,171 | -169 | -504 | -87 | N/A |
12/31/2023 | 1,887 | -396 | -889 | -383 | N/A |
9/30/2023 | 1,752 | -336 | -1,040 | -436 | N/A |
6/30/2023 | 1,455 | -407 | -1,007 | -363 | N/A |
3/31/2023 | 1,196 | -529 | -1,056 | -455 | N/A |
12/31/2022 | 1,023 | -519 | -983 | -428 | N/A |
9/30/2022 | 775 | -609 | -1,080 | -593 | N/A |
6/30/2022 | 510 | -680 | -1,168 | -753 | N/A |
3/31/2022 | 290 | -818 | -1,110 | -797 | N/A |
12/31/2021 | 134 | -867 | -1,057 | -863 | N/A |
9/30/2021 | 10 | -859 | -902 | -798 | N/A |
6/30/2021 | 0 | -809 | -772 | -653 | N/A |
3/31/2021 | 0 | -755 | -757 | -609 | N/A |
12/31/2020 | 0 | -713 | -655 | -537 | N/A |
9/30/2020 | 0 | -709 | -696 | -545 | N/A |
6/30/2020 | 1 | -707 | -623 | -499 | N/A |
3/31/2020 | 2 | -837 | -646 | -505 | N/A |
12/31/2019 | 3 | -795 | -613 | -485 | N/A |
12/31/2018 | 3 | -453 | -191 | -88 | N/A |
12/31/2017 | 6 | -141 | N/A | -93 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688520 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).
Earnings vs Market: 688520 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 688520 is expected to become profitable in the next 3 years.
Revenue vs Market: 688520's revenue (26.7% per year) is forecast to grow faster than the CN market (13.6% per year).
High Growth Revenue: 688520's revenue (26.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 688520's Return on Equity is forecast to be high in 3 years time